Literature DB >> 9168805

Repression of muscle-specific gene activation by the murine Twist protein.

M Hebrok1, A Füchtbauer, E M Füchtbauer.   

Abstract

Inhibition of myogenic differentiation can be achieved by various mechanisms. The murine bHLH protein Twist has been shown to inhibit muscle differentiation in mammalian cells. Here we demonstrate that this inhibition is cell autonomous and does not alter cell proliferation. By overexpression of E12, we can distinguish the inhibitory mechanisms of Twist and the dominant negative HLH factor Id. A difference is seen both for the native muscle-specific enhancers of myogenin and myosin light chain 1/3 and for an enhancer consisting only of four E-boxes. Mutagenesis experiments revealed that both the basic region and an evolutionarily conserved carboxy-terminal domain are required for the Twist-specific type of inhibition. Loss of either of these regions renders Twist less efficient and more similar to Id. Gel mobility shift assays demonstrate that Twist can bind to the muscle creatine kinase E-box and inhibit DNA binding of heterodimers of E12 with myogenic bHLH transcription factors like MyoD. However, a fourfold excess of Twist compared to MyoD is required for both effects. Our results suggest that Twist inhibits muscle-specific gene activation by formation of actively inhibitory complexes rather than by sequestering E-proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9168805     DOI: 10.1006/excr.1997.3541

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis.

Authors:  Vahab D Soleimani; Hang Yin; Arezu Jahani-Asl; Hong Ming; Christel E M Kockx; Wilfred F J van Ijcken; Frank Grosveld; Michael A Rudnicki
Journal:  Mol Cell       Date:  2012-07-05       Impact factor: 17.970

2.  The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist.

Authors:  Y Hamamori; H Y Wu; V Sartorelli; L Kedes
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Increased myogenic repressor Id mRNA and protein levels in hindlimb muscles of aged rats.

Authors:  Stephen E Alway; Hans Degens; Dawn A Lowe; Gururaj Krishnamurthy
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-02       Impact factor: 3.619

4.  Twist is a potential oncogene that inhibits apoptosis.

Authors:  R Maestro; A P Dei Tos; Y Hamamori; S Krasnokutsky; V Sartorelli; L Kedes; C Doglioni; D H Beach; G J Hannon
Journal:  Genes Dev       Date:  1999-09-01       Impact factor: 11.361

5.  Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome.

Authors:  M Yousfi; F Lasmoles; A Lomri; P Delannoy; P J Marie
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

6.  TWIST is expressed in human gliomas and promotes invasion.

Authors:  Maria C Elias; Kathleen R Tozer; John R Silber; Svetlana Mikheeva; Mei Deng; Richard S Morrison; Thomas C Manning; Daniel L Silbergeld; Carlotta A Glackin; Thomas A Reh; Robert C Rostomily
Journal:  Neoplasia       Date:  2005-09       Impact factor: 5.715

7.  Twist alters the breast tumor microenvironment via choline kinase to facilitate an aggressive phenotype.

Authors:  Farhad Vesuna; Marie-France Penet; Noriko Mori; Zaver M Bhujwalla; Venu Raman
Journal:  Mol Cell Biochem       Date:  2022-09-22       Impact factor: 3.842

8.  The proto-oncogene TWIST1 is regulated by microRNAs.

Authors:  Maarja-Liisa Nairismägi; Annette Füchtbauer; Rodrigo Labouriau; Jesper Bertram Bramsen; Ernst-Martin Füchtbauer
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

9.  Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α.

Authors:  F Vesuna; A Lisok; B Kimble; J Domek; Y Kato; P van der Groep; D Artemov; J Kowalski; H Carraway; P van Diest; V Raman
Journal:  Oncogene       Date:  2011-11-07       Impact factor: 9.867

10.  Twist activates miR-22 to suppress estrogen receptor alpha in breast cancer.

Authors:  Farhad Vesuna; Ala Lisok; Paul van Diest; Venu Raman
Journal:  Mol Cell Biochem       Date:  2021-02-13       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.